secwatch.observer — SEC 8-K summary
======================================

Issuer:     SEELOS THERAPEUTICS, INC. (—)
CIK:        0001017491
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001104659-23-062732
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seelos amends Lind note (principal +$1.25M) and issues 4M warrants; authorized shares doubled to 480M
--------------------------------------------------------------------------------

- Lind Note principal increased by $1.25M to $17.75M; May-Sept 2023 payments may be made in cash and stock.
- Issued 1M restricted shares to Lind and 4M warrants (exercise $1.06) to other investors as consideration.
- Stockholders approved increase in authorized common shares from 240M to 480M.
- Leak-out provisions restrict selling by Lind and other holders until Sept 2023 or SLS-002 data release.
- Annual meeting: directors Dalesandro and Pascoe elected; KPMG ratified; say-on-pay advisory vote passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1017491/000110465923062732/0001104659-23-062732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1017491/000110465923062732/tm2316306d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-062732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer